Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
GN Store Nord A/S (GN.CO)
DK CPH Healthcare Medical - Devices
Address
Lautrupbjerg 7 2750
Ballerup, DK
Ballerup, DK
CEO
Peter Karlstromer
Website
gn.com
IPO
2000-10-04
ISIN DK0010272632
Also trades on
NASDAQ Copenhagen · GN.CO (DKK)
Other OTC · GGNDF (USD)
Other OTC · GNNDY (USD)
Description
GN Store Nord A/S, a company founded in 1869 and based in Ballerup, Denmark, specializes in the development, production, and sale of audio and video communication solutions. Its offerings cater to medical, professional, and consumer technology sectors across Denmark, the rest of Europe, North America, and various international markets. The company operates through two distinct segments: GN Hearing and GN Audio. The GN Hearing division is responsible for manufacturing and distributing hearing instruments and related products. Meanwhile, the GN Audio segment supplies an array of devices such as headsets, video cameras, and speakerphones, designed for both professional applications and general consumer use. These products are available under well-known brands including ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
644.0K
Beta
1.38
Float Shares
145.52M
Free Float %
99.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.42% | +0.06% | -0.48% | -2.88% | -11.30% | -13.39% | -0.75% | -47.89% | -80.58% | -26.78% | -57.51% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
95.44
DCF (Unlevered)
74.05
-22.4%
DCF (Levered)
325.11
+240.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
46% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | +1 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
1.72
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-6.1% Q1'26: -47.4% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-33.9% Q1'26: -1,438.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+11.6% ★ Q1'26: +14.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+9.2% ★ Q1'26: -22.5% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+5.8% ★ Q1'26: -7.7% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×3.97× Q1'26: 2.25× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.40B
est: 8.38B (+0.3%)
|
8.65B
est: 8.69B (-0.4%)
|
9.59B
est: 9.57B (+0.1%)
|
10.61B
est: 10.42B (+1.8%)
|
12.57B
est: 12.50B (+0.6%)
|
13.45B
est: 13.49B (-0.3%)
|
15.78B
est: 15.81B (-0.2%)
|
18.69B
est: 18.67B (+0.1%)
|
18.12B
est: 18.31B (-1.1%)
|
17.99B
est: 17.93B (+0.3%)
|
16.88B
est: 17.00B (-0.7%)
|
17.15B
16.84B – 17.45B
+0.9% YoY
|
18.00B
17.43B – 18.88B
+5.0% YoY
|
18.89B
18.42B – 19.53B
+4.9% YoY
|
19.87B
19.38B – 20.54B
+5.2% YoY
|
20.68B
20.17B – 21.38B
+4.1% YoY
|
| EBITDA |
1.97B
est: 1.46B (+34.9%)
|
2.06B
est: 1.51B (+35.9%)
|
2.30B
est: 1.67B (+37.5%)
|
2.39B
est: 1.82B (+31.5%)
|
3.19B
est: 2.18B (+46.1%)
|
2.81B
est: 2.35B (+19.6%)
|
3.60B
est: 2.76B (+30.4%)
|
2.50B
est: 3.26B (-23.3%)
|
2.31B
est: 3.04B (-23.8%)
|
3.12B
est: 2.97B (+5.0%)
|
2.81B
est: 2.82B (-0.5%)
|
2.84B
2.79B – 2.89B
+0.9% YoY
|
2.98B
2.89B – 3.13B
+5.0% YoY
|
3.13B
3.05B – 3.24B
+4.9% YoY
|
3.29B
3.21B – 3.41B
+5.2% YoY
|
3.43B
3.34B – 3.54B
+4.1% YoY
|
| EBIT |
1.07B
est: 820.55M (+30.8%)
|
1.48B
est: 850.90M (+73.5%)
|
1.67B
est: 937.43M (+77.8%)
|
1.71B
est: 1.02B (+67.5%)
|
2.22B
est: 1.22B (+81.1%)
|
1.78B
est: 1.32B (+34.9%)
|
2.47B
est: 1.55B (+59.7%)
|
1.01B
est: 1.83B (-44.7%)
|
899.00M
est: 1.65B (-45.4%)
|
1.74B
est: 1.61B (+8.0%)
|
1.56B
est: 1.53B (+1.8%)
|
1.54B
1.51B – 1.57B
+0.9% YoY
|
1.62B
1.57B – 1.70B
+5.0% YoY
|
1.70B
1.66B – 1.76B
+4.9% YoY
|
1.79B
1.74B – 1.85B
+5.2% YoY
|
1.86B
1.81B – 1.92B
+4.1% YoY
|
| Net Income |
805.00M
est: 847.34M (-5.0%)
|
1.03B
est: 1.08B (-4.8%)
|
1.18B
est: 1.27B (-6.7%)
|
1.24B
est: 1.43B (-13.0%)
|
1.45B
est: 1.73B (-16.0%)
|
1.25B
est: 1.40B (-10.5%)
|
1.76B
est: 2.04B (-13.9%)
|
511.00M
est: 1.44B (-64.5%)
|
228.00M
est: 600.00M (-62.0%)
|
988.00M
est: 1.16B (-15.2%)
|
653.00M
est: 839.08M (-22.2%)
|
1.01B
34.87M – 1.61B
+20.3% YoY
|
1.25B
884.14M – 1.62B
+24.1% YoY
|
1.64B
1.38B – 1.90B
+30.9% YoY
|
1.83B
1.77B – 1.91B
+11.7% YoY
|
1.78B
1.72B – 1.86B
-2.8% YoY
|
| SGA |
2.95B
est: 2.35B (+25.3%)
|
3.14B
est: 2.44B (+28.9%)
|
3.55B
est: 2.69B (+32.1%)
|
3.76B
est: 2.92B (+28.4%)
|
4.28B
est: 3.51B (+21.9%)
|
4.39B
est: 3.78B (+15.9%)
|
4.69B
est: 4.44B (+5.7%)
|
6.15B
est: 5.24B (+17.4%)
|
5.78B
est: 4.45B (+29.9%)
|
2.37B
est: 4.35B (-45.5%)
|
2.31B
est: 4.13B (-43.9%)
|
4.16B
4.09B – 4.24B
+0.9% YoY
|
4.37B
4.23B – 4.59B
+5.0% YoY
|
4.59B
4.47B – 4.74B
+4.9% YoY
|
4.82B
4.70B – 4.99B
+5.2% YoY
|
5.02B
4.90B – 5.19B
+4.1% YoY
|
| EPS |
5.16
est: 5.82 (-11.3%)
|
6.98
est: 7.44 (-6.2%)
|
8.51
est: 8.70 (-2.2%)
|
9.25
est: 9.79 (-5.5%)
|
11.12
est: 11.88 (-6.4%)
|
9.72
est: 9.60 (+1.2%)
|
13.63
est: 13.99 (-2.6%)
|
4.00
est: 9.88 (-59.5%)
|
1.64
est: 4.12 (-60.2%)
|
6.79
est: 7.95 (-14.6%)
|
4.48
est: 5.72 (-21.7%)
|
6.95
0.24 – 11.06
+21.4% YoY
|
9.09
6.07 – 11.12
+30.7% YoY
|
11.25
9.46 – 13.04
+23.9% YoY
|
12.57
12.16 – 13.12
+11.7% YoY
|
12.22
11.82 – 12.75
-2.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.37B
OE per share TTM
16.24
Owner's Yield
17.02%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
6.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 82 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Denmark ETF EDEN | 0.84% | 1.73M | 0.53% |
| 2 | Vident International Equity Strategy ETF VIDI | 0.32% | 1.27M | 0.61% |
| 3 | Global X - Aging Population ETF AGNG | 0.28% | 237.9K | 0.50% |
| 4 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.16% | 546.1K | 0.23% |
| 5 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.16% | 546.1K | 0.23% |
| 6 | Dimensional - International Small Cap Value ETF DISV | 0.16% | 7.53M | 0.42% |
| 7 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.14% | 1.11M | 0.30% |
| 8 | iShares MSCI Europe Small-Cap ETF IEUS | 0.12% | 213.5K | 0.41% |
| 9 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.12% | 4.04M | 0.30% |
| 10 | Dimensional - International Small Cap ETF DFIS | 0.09% | 5.10M | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
213.0K
Shares Outstanding
145.61M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter Karlstromer | Chief Executive Officer | 16M | male |
| Soren Jelert | Chief Financial Officer | 8M | male |
| Brian Dam Pedersen | Chief Technical Officer | — | male |
| Calum MacDougall | President of Enterprise Division | — | male |
| Ehtisham Rabbani | President of Gaming Division | — | male |
| Igor Tasevski | Chief Product Officer | — | male |
| Peter Justesen | President of Hearing division | — | male |
| Rune Sandager | Head of Investor Relations | — | male |
| Steen Frentz Laursen | Vice President of Group Communication | — | male |
| Ann Fogelgren | Chief Information Officer | — | female |
| Stefan Bergfors | Chief Operations Officer | — | male |
| Anu Helena Kerns | Chief People & Communication Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GN.CO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
